Keyphrases
Thrombotic
100%
Femoral Head Osteonecrosis
100%
Fibrinolytic Disorders
100%
Control Subjects
33%
Immunoglobulin G
33%
Plasminogen Activator inhibitor-1 (PAI-1)
33%
Anticardiolipin Antibodies
33%
Tissue Plasminogen Activator (t-PA)
33%
East Asian Patients
33%
Prothrombotic Factors
33%
Fibrinolytic Factors
33%
No Significant Difference
16%
Protein Activity
16%
Lipoproteins
16%
Immunoglobulin M
16%
Consecutive Patients
16%
Antiphospholipid Antibodies
16%
Plasminogen
16%
Presentation Time
16%
Protein C Activity
16%
Antithrombin III (ATIII)
16%
Idiopathic Osteonecrosis
16%
Lupus Antibodies
16%
Medicine and Dentistry
Disease
100%
Osteonecrosis Of The Femoral Head
100%
Immunoglobulin G
33%
Cardiolipin Antibody
33%
Tissue Plasminogen Activator
33%
Fibrinolytic Factor
33%
Anti-Cardiolipin Antibodies
33%
Plasminogen Activator Inhibitor-1
33%
Immunoglobulin M
16%
Lipoprotein
16%
Lupus Erythematosus
16%
Antiphospholipid Antibody
16%
Bone Necrosis
16%
Case-Control Study
16%
Protein S
16%
Protein C
16%
Plasminogen
16%
Antithrombin III
16%
Nursing and Health Professions
Disease
100%
Bone Necrosis
100%
Fibrinolytic Agent
100%
Cardiolipin Antibody
28%
Plasminogen Activator Inhibitor 1
28%
Tissue Plasminogen Activator
28%
Fibrinolytic Factor
28%
Immunoglobulin G
28%
Case-Control Study
14%
Lipoprotein A
14%
Phospholipid Antibody
14%
Plasminogen
14%
Antithrombin III
14%
Protein S
14%
Protein C
14%
Immunoglobulin M
14%